Author:
Ranganatha Priyanka,Burugina Nagaraja Sharath,Shivanna Ragunatha
Reference17 articles.
1. Central Leprosy Division. NLEP Annual Report 2015–2016. National Leprosy Eradication Programme. 2016; Annual Rep. [Internet]. Available from: http://www.fareshare.org.uk/wp-content/uploads/2016/09/FareShare_Annual_Report_2016_Interactive.pdf.
2. Rao PN, Suneetha S. Current situation of leprosy in India and its future implications. Indian Dermatology Online Journal, 2018 [cited 2019 Jun 21]; 9(2):83. [Internet]. Available from: http://www.ncbi.nlm.nih.gov/pubmed/29644191.
3. Bilodeau M, Burns S, Gawoski J, Moschella S, Ooi W. Co-morbid infections in Hansen’s disease patients in the United States: considerations for treatment. Am J Trop Med Hyg, 2013; 89(4): 781–783, [Internet]. Available from: http://www.ncbi.nlm.nih.gov/pubmed/23980128.
4. Saraya MA, Al-Fadhli MA, Qasem JA. Diabetic status of patients with leprosy in Kuwait. Journal of Infection and Public Health, 2012; 5(5): 360–365, [Internet]. Available from: http://dx.doi.org/10.1016/j.jiph.2012.08.001.
5. Ozturk S, Ozturk T, Can I. Renal involvement in leprosy: evaluation of patients in Turkey. 2017; 10145.